Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational... see more

NDAQ:PMN - Post Discussion

ProMIS Neurosciences Inc > Nasal Spray to cure AD! Human Trials
View:
Post by JackRedwood on Nov 18, 2021 10:23am

Nasal Spray to cure AD! Human Trials

It seems like they are already testing on Humans with a new AD drug that is used as a Nasal Spray! Clinical Trials are being done as we speak. 

PMN like their so called Covid Test is wasting time or diluting the Company into oblivion. 

Not fair to long term Shareholders! 

article;
https://www.cbsnews.com/news/alzheimers-disease-nasal-vaccine-human-trial-to-begin-at-boston-hospital/

Comment by BottomBroker on Nov 18, 2021 10:44am
And it's taken them 20 years to get there. These things don't happen overnight. 
Comment by retiredcop on Nov 18, 2021 12:10pm
Excellent news...  Thanks to biogen, another compnay targeting amyloids again .. we need more and more research to target this area  
Comment by JackRedwood on Nov 18, 2021 12:17pm
Agreed 100%
Comment by Bookworm28 on Nov 18, 2021 6:51pm
I feel your frustration. I'm trying to figure out if these guys are for real or not. I look over the year's NRs, and they apparently have this fantastic PM310 antibody, but not much is happening. I know this type of tech progresses slowly, but they need to give us something tangible. Something other than their cell-line NR from May. What do they do day to day? Do they have specific people ...more  
Comment by JackRedwood on Nov 18, 2021 7:38pm
Great post! 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities